SCHEMBL6509187

SCHEMBL6509187

O=Cc1ccc(OC(C(=O)O)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A3 P47895 1/20 0.49
KMT2A Q03164 3/20 0.47
PTPN1 P18031 2/20 0.46
DRD1 P21728 1/20 0.45
PPARA Q07869 3/20 0.43
PPARG P37231 2/20 0.43
MEN1 O00255 2/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
LTB4R Q15722 1/20 0.43
LTB4R2 Q9NPC1 1/20 0.43
CYP2D6 P10635 1/20 0.42
CHRM1 P11229 1/20 0.42
CYP2A6 P11509 1/20 0.42
POLB P06746 1/20 0.41
CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13220868 0.84 KMT2A (0.51) ALDH1A1KDM4EALDH1A3KMT2ADRD1
SCHEMBL2554873 0.84 MAOA (0.49) ALDH1A1KDM4EKMT2APPARAPPARG
SCHEMBL21881586 0.84 KDM4E (0.55) ALDH1A1KDM4EKMT2APTPN1PPARA
SCHEMBL660871 0.84 KDM4E (0.55) ALDH1A1KDM4EKMT2APTPN1PPARA
SCHEMBL13324879 0.84 KDM4E (0.55) ALDH1A1KDM4EKMT2APTPN1PPARA
Hydrogen Sulfide SCHEMBL28780976 0.82 KDM4E (0.54) ALDH1A1KDM4EKMT2APTPN1PPARA
SCHEMBL23031155 0.79 ALDH1A3 (0.52) ALDH1A1KDM4EALDH1A3KMT2ADRD1
SCHEMBL21881560 0.79 MEN1 (0.58) ALDH1A1KDM4EKMT2APPARAPPARG
SCHEMBL21881525 0.79 PPARG (0.59) ALDH1A1KDM4EKMT2APPARAPPARG
SCHEMBL21881189 0.79 PPARG (0.55) ALDH1A1KDM4EKMT2APTPN1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
US-20050070558-A1 6-Phenyldihydropyrrolopyrimidinedione derivatives ALMIRALL PRODESFARMA S.A. (ES) 2005-03-31 US disclosed
EP-1409489-A1 6-PHENYLDIHYDROPYRROLOPYRIMIDINEDIONE DERIVATIVES Almirall Prodesfarma, S.A. (ES) 2004-04-21 EP disclosed
WO-2003000694-A1 6-PHENYLDIHYDROPYRROLOPYRIMIDINEDIONE DERIVATIVES ALMIRALL PRODESFARMA S.A. (ES) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070558-A1 6-Phenyldihydropyrrolopyrimidinedione derivatives ADORA1, ADORA2A, P2RY10 ALDH1A1 230/4885KDM4E 4085/4885ALDH1A3 1258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.